At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
03696 INSILICO
Closed Good Friday 04-02 16:08:21
57.250
-3.550
-5.84%
High62.550Low55.750Vol4.66M
Open62.550D1 Closing60.800Amplitude11.18%
Mkt Cap32.73BTradable Cap32.73BTotal Shares571.62M
T/O269.10MT/O Rate0.82%Tradable Shares571.62M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Stock Track | INSILICO Soars 11.79% Intraday on $2.75 Billion Eli Lilly AI Drug Collaboration
Stock Track  ·  04-01 11:31
Stock Track | INSILICO Soars 11.79% Intraday on $2.75 Billion Eli Lilly AI Drug Collaboration
INSILICO Shares Surge Over 10% in Morning Trading Following $2.75 Billion Partnership with Eli Lilly; CEO Affirms Commitment to Independence
Stock News  ·  04-01 10:29
INSILICO Shares Surge Over 10% in Morning Trading Following $2.75 Billion Partnership with Eli Lilly; CEO Affirms Commitment to Independence
Stock Track | Insilico Medicine Soars 5.28% Intraday on Potential $2.75 Billion Eli Lilly Deal
Stock Track  ·  03-31
Stock Track | Insilico Medicine Soars 5.28% Intraday on Potential $2.75 Billion Eli Lilly Deal
Insilico Medicine Cayman TopCo FY 2025 Loss Deepens To US$352.3 Million Challenging Bullish Narratives
Simply Wall St.  ·  03-30
Insilico Medicine Cayman TopCo FY 2025 Loss Deepens To US$352.3 Million Challenging Bullish Narratives
Deals of the day-Mergers and acquisitions
Reuters  ·  03-30
Deals of the day-Mergers and acquisitions
Stocks to Watch: Alcoa, Peloton, TotalEnergies -- WSJ
Dow Jones  ·  03-30
Stocks to Watch: Alcoa, Peloton, TotalEnergies -- WSJ
PRESS DIGEST -Wall Street Journal - March 30
Reuters  ·  03-30
PRESS DIGEST -Wall Street Journal - March 30
INSILICO Inks $2.75 Billion Landmark Partnership, Highlighting Long-Term Investment Value
Stock News  ·  03-30
INSILICO Inks $2.75 Billion Landmark Partnership, Highlighting Long-Term Investment Value
InSilico Medicine's Loss Widens in 2025; Enters Licensing Agreement With Eli Lilly
MT Newswires Live  ·  03-30
InSilico Medicine's Loss Widens in 2025; Enters Licensing Agreement With Eli Lilly
PRESS DIGEST-Financial Times - March 30
Reuters  ·  03-30
PRESS DIGEST-Financial Times - March 30
Stock Track | Insilico Medicine Soars 14.95% Intraday on Major $2.8 Billion AI Drug Discovery Deal with Lilly
Stock Track  ·  03-30
Stock Track | Insilico Medicine Soars 14.95% Intraday on Major $2.8 Billion AI Drug Discovery Deal with Lilly
Insilico Medicine Announces Global R&D Collaboration With Lilly
THOMSON REUTERS  ·  03-30
Insilico Medicine Announces Global R&D Collaboration With Lilly
Insilico Reports Annual Results with Over 10 New Partnerships and $393 Million Cash Reserves
Stock News  ·  03-29
Insilico Reports Annual Results with Over 10 New Partnerships and $393 Million Cash Reserves
Insilico Medicine signs Lilly collaboration worth up to USD 2.8 billion
Reuters  ·  03-29
Insilico Medicine signs Lilly collaboration worth up to USD 2.8 billion
Insilico Medicine FY25 loss widens to US$352.3 million; revenue drops 34.5% to US$56 million
Reuters  ·  03-29
Insilico Medicine FY25 loss widens to US$352.3 million; revenue drops 34.5% to US$56 million
INSILICO Enters Global Licensing and AI Drug Development Partnership with Eli Lilly
Stock News  ·  03-29
INSILICO Enters Global Licensing and AI Drug Development Partnership with Eli Lilly
InSilico Medicine: 2025 Revenue Falls 34.5% to US$56.24 Million; Net Loss Swells to US$352.32 Million
Bulletin Express  ·  03-29
InSilico Medicine: 2025 Revenue Falls 34.5% to US$56.24 Million; Net Loss Swells to US$352.32 Million
BRIEF-Insilico Medicine Cayman TopCo Reports 2025 Revenue Of $56.2 Million
Reuters  ·  03-29
BRIEF-Insilico Medicine Cayman TopCo Reports 2025 Revenue Of $56.2 Million
Insilico Medicine Cayman Topco 2025 Revenue $56.2 Mln
THOMSON REUTERS  ·  03-29
Insilico Medicine Cayman Topco 2025 Revenue $56.2 Mln
Eli Lilly To Sign $2 Bln Deal For AI Drug Development With Hong Kong Biotech Insilico Medicine - FT
Reuters  ·  03-29
Eli Lilly To Sign $2 Bln Deal For AI Drug Development With Hong Kong Biotech Insilico Medicine - FT

Introduction

Company Name.
INSILICO
Affiliated Markets:
SEHK
Listing Date:
--
Main Business:
InSilico Medicine Cayman TopCo is a company principally engaged in the research and development of artificial intelligence in pharmaceuticals. The Company is engaged in the research and development of drug discovery engines. In addition, the Company is engaged in the copabdrug discovery and development of disease target identification, generation of novel molecules data, and predicting clinical trial outcomes.
Issue price:
--